parkinson glutathione oxidative ipsc crispr Frontiers Non-invasive CRISPR/Cas9 nanocapsules specifically edit
Non invasive CRISPR Cas9 nanocapsules specifically edit synuclein for effective Parkinson's disease treatment ScienceDirect Parkinson's disease linked parkin mutation disrupts recycling of synaptic vesicles in human dopaminergic neurons: Neuron Using iPS Cells toward the Understanding of Parkinson's Disease The Mitochondrial Interactome in Parkinson's and Huntington's Diseases Nature Cell and Science Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024 Journal of Molecular Medicine Springer Nature Link
Pay in 4 interest-free payments of $5.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




